跳至主要内容
临床试验/NCT00386022
NCT00386022Unknown2 期

The Effect of Aging on the Isolated Pituitary Response to Gonadotropin Releasing Hormone at Baseline and With Low Dose Estrogen Administration

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2002年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
19
试验地点
1
主要终点
Pituitary Response to GnRH

研究概览

简要总结

The purpose of this study is to study the effects of aging and estrogen on the brain. Specifically, this study will examine how the hypothalamus signals the pituitary gland to secrete reproductive hormones and how that changes with aging.

详细描述

Although it is clear that loss of ovarian function plays a major role in the menopause in women, there is evidence from animal studies that primary age-related hypothalamic and pituitary changes may also contribute to reproductive aging. Complete cessation of ovarian function results in the loss of negative feedback of ovarian steroids and inhibin on the hypothalamic and pituitary components of the reproductive axis. An increase in serum levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) occurs in postmenopausal women with removal of negative ovarian feedback. However, levels of LH and FSH after menopause decline steadily as a function of age in most though not all studies.

The current study is designed to determine: 1) whether negative feedback on LH and FSH occurs at the pituitary; and 2) whether there is an effect of aging on estrogen negative feedback at the pituitary. Younger and older postmenopausal women underwent a baseline study and a second identical study after a month of low dose estrogen replacement. The study protocol consisted of the following: 1) administration of a GnRH antagonist (Nal-Glu at 150 mg/kg that blocks endogenous GnRH so that the dose and interval of pituitary exposure to GnRH are precisely controlled; 2) beginning 8 hours following GnRH antagonist administration (at a time when LH had reached its nadir following GnRH receptor blockade), administration of 4 graded doses of GnRH (25, 75, 250 and 750 ng/kg every 2 hours with 2 hours of blood draws following each dose). Blood was sampled every 30 min for 4 hours before antagonist administration, every 30 min for the following 7 hours and then every 10 min until the completion of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Other
盲法
None

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 45-55 or 70-80 years old
  • History of natural menopause defined by the absence of menses for at least 12 months (or history of surgical menopause defined as bilateral oophorectomy) and a FSH level >26 IU/L
  • On no hormonal medication or herbal supplements and/or over the counter menopause therapy for a minimum of 2 months prior to study
  • Normal thyroid stimulating hormone, prolactin, factor V Leiden, and complete blood count - Normal blood urea nitrogen and creatinine (< 2 times the upper limit of normal)
  • basal metabolic index ≤ 30
  • Non-smokers or smoke less than 10 cigarettes/day

排除标准

  • Absolute contraindications to the use of physiologic replacement doses of estrogen, including a negative screening mammogram within the past 24 months
  • History of coronary artery disease
  • On medications thought to act centrally on the GnRH pulse generator
  • Past history of hypersensitivity or allergy to narcotics, vancomycin, muscle relaxants, aspirin, and/or anaphylactic reaction(s) to other drugs
  • Prior history of breast cancer and/or blood clots

研究组 & 干预措施

Young postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: GnRH (Drug)

Young postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: NAL-GLU GnRH antagonist (Drug)

Young postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: Estrogen patch (Drug)

Older postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: GnRH (Drug)

Older postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: NAL-GLU GnRH antagonist (Drug)

Older postmenopausal women

Experimental

intervention: graded doses of GnRH following NAL-GLU GnRH antagonist administration with or without transdermal estrogen patch

干预措施: Estrogen patch (Drug)

结局指标

主要结局

Pituitary Response to GnRH

时间窗: Peak hormone level within 2 hours post GnRH doses

Baseline LH and FSH responses to each of 4 GnRH doses - peak to nadir amplitude expressed as percent (%) change from nadir

Effect of Estrogen on Pituitary Response to GnRH

时间窗: Peak hormone level within 2 hours post GnRH doses

LH and FSH responses to each of 4 GnRH doses, expressed as change in amplitude \[amp\] from peak to nadir between plus estrogen and baseline conditions

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janet E. Hall, MD

Associate Physician

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验

The Effects of Aging and Estrogen on the Pituitary | 临床试验